Basal-like breast cancer: A review

被引：4
|
作者：
Treilleux, Isabelle [1 ]
Morellon-Mialhe, Blandine [1 ]
机构：
[1] Ctr Leon Berard, Serv Anat Pathol, F-69373 Lyon 08, France
来源：
ANNALES DE PATHOLOGIE | 2009年 / 29卷 / 03期
关键词：
Breast cancer; Basal phenotype; Basal cytokeratins; Myoepithelial markers; Immunohistochemistry; Prognosis; IN-SITU HYBRIDIZATION; DUCTAL CARCINOMA; EPITHELIAL PHENOTYPE; EXPRESSION; SUBTYPE; AMPLIFICATION; MUTATIONS; RECEPTOR; MARKERS; EGFR;
D O I：
10.1016/j.annpat.2009.04.001
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Breast cancers of basal phenotype have been identified by molecular profiting and are associated with a poor prognosis. This review describes the morphological characteristics of these tumors and focuses on their profiting using immunohistochemistry: absence of detectable hormone receptors and HER2, expression of basal cytokeratins (CK5/6, CK14), myoepithelial markers (p63, smooth muscle actin) and HER1. This phenotype may be encountered in all histological types of breast cancer and is further divided into three subtypes according to prognosis and protein profiting. Pure basal and basal/myoepithelial subtypes have a poor prognosis in contrast to the myoepithelial subtype. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：180 / 186
页数：7
相关论文
共 50 条
  • [1] Basal-like breast cancer: A critical review
    Rakha, Emad A.
    Reis-Filho, Jorge S.
    Ellis, Ian O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2568 - 2581
  • [2] Epidemiology of basal-like breast cancer
    Robert C. Millikan
    Beth Newman
    Chiu-Kit Tse
    Patricia G. Moorman
    Kathleen Conway
    Lisa V. Smith
    Miriam H. Labbok
    Joseph Geradts
    Jeannette T. Bensen
    Susan Jackson
    Sarah Nyante
    Chad Livasy
    Lisa Carey
    H. Shelton Earp
    Charles M. Perou
    Breast Cancer Research and Treatment, 2008, 109 : 123 - 139
  • [3] Epidemiology of basal-like breast cancer
    Millikan, Robert C.
    Newman, Beth
    Tse, Chiu-Kit
    Moorman, Patricia G.
    Conway, Kathleen
    Smith, Lisa V.
    Labbok, Miriam H.
    Geradts, Joseph
    Bensen, Jeannette T.
    Jackson, Susan
    Nyante, Sarah
    Livasy, Chad
    Carey, Lisa
    Earp, H. Shelton
    Perou, Charles M.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 123 - 139
  • [4] Epidemiology of basal-like breast cancer
    Robert C. Millikan
    Beth Newman
    Chiu-Kit Tse
    Patricia G. Moorman
    Kathleen Conway
    Lynn G. Dressler
    Lisa V. Smith
    Miriam H. Labbok
    Joseph Geradts
    Jeannette T. Bensen
    Susan Jackson
    Sarah Nyante
    Chad Livasy
    Lisa Carey
    H. Shelton Earp
    Charles M. Perou
    Breast Cancer Research and Treatment, 2008, 109 : 141 - 141
  • [5] Triple-negative/basal-like breast cancer: review
    Rakha, Emad A.
    Ellis, Ian O.
    PATHOLOGY, 2009, 41 (01) : 40 - 47
  • [6] Triple negative, "basal-like" breast cancer: an institutional review
    Herms, B. T.
    Jain, D.
    Chagpar, A. B.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S278 - S279
  • [7] The role of RhoGAPs in basal-like breast cancer
    Lawson, C. D.
    Rossman, K. L.
    Fan, C.
    Perou, C. M.
    Burridge, K.
    Der, C. J.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [8] Immunohistochemical characteristics of basal-like breast cancer
    Badowska-Kozakiewicz, Anna M.
    Budzik, Michal P.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (06): : 436 - 443
  • [9] Unraveling the complexity of basal-like breast cancer
    Marotta, Lauren L. C.
    Polyak, Kornelia
    ONCOTARGET, 2011, 2 (08) : 588 - 589
  • [10] Molecular insights on basal-like breast cancer
    Valentin, Mev Dominguez
    da Silva, Sabrina Daniela
    Privat, Maud
    Alaoui-Jamali, Moulay
    Bignon, Yves-Jean
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 21 - 30
12345